Velit Biopharma

Milan, Italy Founded: 2018 • Age: 8 yrs Acquired By Kelsopharma.com
Pharmaceutical company that specializes in the development, distributing, and manufacturing of bio and nano pharmaceuticals, medical devices, and food supplements

About Velit Biopharma

Velit Biopharma is a Healthcare company based in Milan (Italy) founded in 2018 by Nicola Travierso, and was acquired by Kelsopharma.com in November 2023. Pharmaceutical company that specializes in the development, distributing, and manufacturing of bio and nano pharmaceuticals, medical devices, and food supplements. Velit Biopharma offers products and services including Biopharmaceuticals, Nano-pharmaceuticals, Medical Devices, and Food Supplements. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include Admenta Italia, LaNova Farmaceutici and FL Group.

Company details

Velit is a biopharmaceutical company that specializes in the development and manufacturing of pharmaceuticals, medical devices, and food supplements. They offer a range of products in these categories and are headquartered in Milan, Italy.

  • Headquarters Milan, Italy
  • Founders Nicola Travierso
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website velitnb.com
  • Social LinkedIn
  • Acquired by Kelsopharma.com (Nov 2023)
Key Metrics

Products & Services of Velit Biopharma

Velit Biopharma offers a comprehensive portfolio of products and services, including Biopharmaceuticals, Nano-pharmaceuticals, Medical Devices, and Food Supplements.

Biopharmaceuticals
Pharmaceuticals

Development and supply of biopharmaceutical products for medical use.

Nano-pharmaceuticals
Pharmaceuticals

Advanced nano-based solutions for targeted drug delivery.

Medical Devices
Healthcare Devices

Production of patches and films for patient care applications.

Food Supplements
Nutraceuticals

Supply of supplements to support health and wellness needs.

Investors in Velit Biopharma

Velit Biopharma has secured backing from 1 investor. Prominent investors backing the company include Kelsopharma.com.

All
InvestorDescriptionFounded YearDomainLocation
R&D company focused on manufacturing of drugs for multiple therapeutic areas
2020kelsopharma.comUnited Kingdom
Premium access

Investor details for Velit Biopharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Velit Biopharma

3 people are tracked at Velit Biopharma (2 in leadership, 1 in team).

NameRoleGroup
Nicola Travierso
FounderLeadership
Serena Mortella
Finance Business PartnerLeadership
Mattia Eleftheriou
Business Development & Marketing AssociateTeam
Premium access

Complete people profiles for Velit Biopharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Velit Biopharma

2 dated milestones of Velit Biopharma across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Velit Biopharma is founded.
  2. Exit Acquired by Kelsopharma.com.

Competitors of Velit Biopharma

Velit Biopharma has 3 listed competitors in our database. They include Admenta Italia, LaNova Farmaceutici and FL Group.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
admentaitalia.it2003Milan, Italy
Provides wholesale pharmaceutical sales, retail pharmacies, and industry services in Italy.
lanovafarmaceutici.com2010Roma, Italy
Company specializes in sales, promotion, and distribution of drugs, medical devices, supplements, and cosmetics
fl-group.it2013Vado Ligure, Italy
Cannabis raw materials services are provided by FL Group.
Premium access

Detailed competitors of Velit Biopharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Velit Biopharma

Premium access

Complete news archive for Velit Biopharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Velit Biopharma

Velit Biopharma was founded in 2018.

Velit Biopharma is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.

Velit is a biopharmaceutical company that specializes in the development and manufacturing of pharmaceuticals, medical devices, and food supplements. They offer a range of products in these categories and are headquartered in Milan, Italy.

Velit Biopharma's top competitors include FL Group, LaNova Farmaceutici and Admenta Italia.

Velit Biopharma offers Biopharmaceuticals, Nano-pharmaceuticals, Medical Devices, and Food Supplements.

Velit Biopharma has 1 investor. Key investors include Kelsopharma.com.

Yes. Velit Biopharma was acquired by Kelsopharma.com in November 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available